Dibutyl phthalate |CAS 84-74-2|DC Chemicals

Cas No.:	84-74-2
Chemical Name:	Dibutyl phthalate
Synonyms:	Dibutyl phthalate;1,2-benzenedicarboxylic acid dibutyl ester;ARALDITE RESIN;Benzenedicarboxylic acid dibutyl ester;DBP;DBP(R);DIBUTYL 1,2-BENZENEDICARBOXYLATE;DI-N-BUTYL PHTHALATE;DL-N-BUTYL PHTHALATE;N-BUTYL PHTHALATE;O-BENZENEDICARBOXYLIC ACID DIBUTYL ESTER;PHTHALIC ACID, BIS-BUTYL ESTER;PHTHALIC ACID DIBUTYL ESTER;PHTHALIC ACID DI-N-BUTYL ESTER;ai-3-00283;benzene-1,2-dicarboxylicaciddibutylester;Benzene-o-dicarboxylic acid, di-n-butyl ester;Bufa;1,2-Benzenedicarboxylic acid;Dibutyl phthalate solution;Dibutyl Phthalate-13C6,d4;Di-n-butyl phthalate (DBP);Di-n-butyl phthalate solution;Phthalic acid butyl ester;1,2-dibutyl 1,2-benzenedicarboxylate;1000μg;2,6-di-t-butyl-4-methyl-phenol;butyl dibutylphosphinate;butyl phthalate;Butylester of dibutylphosphinic acid;dibutyl benzene-1,2-dicarboxylate;dibutyl-phosphinic acid butyl ester;Dibutylphosphinsaeure-butylester;dibutylphosphonic acid butyl ester;Phosphinic acid,dibutyl-,butyl ester;Celluflex DPB;Elaol;Genoplast B;Palatinol C;Polycizer DBP;Unimoll DB;DIBUTYLPHTHALATE;Dibutyl-o-phthalate;Staflex DBP;Hexaplas M/B;Ergoplast FDB;Kodaflex DBP;DBP (ester);N-Butylphthalate;Ersoplast FDA;Phthalate, di-n-butyl;Uniflex DBP;Hatcol DBP;Dibutyl o-phthalate;RC Plasticizer DBP;1,2-Benzenedicarboxylic ac;Palatinol DBP;dibutyl phthalate; DBP;Phthalic acid di-n-butyl ester;Butyl phthalate;DIBUTYL PHTHALATE (II);KBio2_002532;DIBUTYL PHTHALATE [USP-RS];Uniplex 150;NA9095;CHEBI:34687;S5377;KBioGR_001267;NCGC00254882-01;di-n-butyl phthalate (dbp);HSDB 922;Dibutyl-1,2-benzenedicarboxylate;BDBM50371946;NSC 6370;2286E5R2KE;MLS002177802;KBio2_007668;Di(n-butyl) 1,2-benzenedicarboxylate;Ruifeng vp 201;ortho-Dibutyl phthalate;CS-0013564;CHEMBL272485;Bisoflex DBP;Ftalato di n-butanolo;Dibutyl phthalate, >=99%;Dibutyl phthalate, United States Pharmacopeia (USP) Reference Standard;Phthalic acid dibutyl ester;Dibutyl phthalate, PESTANAL(R), analytical standard;NCGC00090769-08;SpecPlus_000628;BRN 1914064;Dibutyl phthalate [NF];DB13716;NCGC00090769-01;Di(1-butyl) phthalate;Dibutyl-1,2-benzene-dicarboxylate;SMR000777923;Dibutyl phthalate, SAJ special grade, >=98.0%;KBio3_002047;Benzol-1,2-dicarbonsauredibutylester;Q415612;Witcizer 300;RAPIDCELLtrade markP;HMS3041E18;Phthalic acid, dibutyl ester;Dibutyl 1, 2-benzenedicarboxylate;NCGC00259278-01;Dibutyl Phthalate, Pharmaceutical Secondary Standard; Certified Reference Material;Benzene-o-dicarboxylic acid di-n-butyl ester;Dibutyl 1,2-benzene-dicarboxylate;Dibutylftalat;Ersoplast FDA.;dibutyl phthalate;Dibutyl phthalate, LR, >=98%;Di-n-butyl phthalate;Phthalic acid, bis-butyl ester;Di n Butyl Phthalate;RCRA waste number U069;SR-05000001549-3;DIBUTYL PHTHALATE [MART.];DIBUTYL PHTHALATE (SEE ALSO PEROXISOME PROJECT (DIBUTYL PHTHALATE));Phthalate, Dibutyl;di-n-butyl phthalate (DBuP);Sicol 140;Dibutyl phthalate, Selectophore(TM);o-Benzenedicarboxylic acid, dibutyl ester;D...
SMILES:	O=C(C1C(C(OCCCC)=O)=CC=CC=1)OCCCC
Formula:	C₁₆H₂₂O₄
M.Wt:	278.343485355377
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

In Vitro Dibutyl phthalate (0.001 µg/mL-1000 µg/mL) is detrimental to follicle growth and viability and results in significant dysregulation of cell cycle and apoptosis gene expression in a dose-specific manner. But MBP does not play a role in Dibutyl phthalate toxicity in follicles exposed in vitro. In Vivo Dibutyl phthalate (200, 400, or 600 mg/kg/day) induces decrease mice weight, impairment of spermatogenesis, reduces serum follicle stimulating hormone and testosterone level, alters testicular LDH, increases LPO, and decreases the levels of enzymatic antioxidants with histopathological anomalies. Dibutyl phthalate (6.25, 12.5, 25, 50, 100 and 200 mg/kg) could cause some neurobehavioral adverse effects in mice.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.